Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study

BACKGROUND: Anthracycline-based adjuvant chemotherapy improves survival in patients with high-risk node-negative breast cancer (BC). In this setting, prognostic factors predicting for treatment failure might help selecting among the different available cytotoxic combinations. METHODS: Between 1998 a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Rahal, S., Boher, J M, Extra, J M, Tarpin, C., Charafe-Jauffret, E., Lambaudie, E., Sabatier, R., Thomassin-Piana, J., Tallet, A., Resbeut, M., Houvenaeghel, G., Laborde, L., Bertucci, F., Viens, P., Gonçalves, A.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4607139/
https://ncbi.nlm.nih.gov/pubmed/26466893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1746-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados